So-called “may contains”, or advisory labels on packaged foods, are confusing for allergic consumers and can even be dangerous
A new pilot study has resulted in subjects being able to tolerate 160 to 400 times more peanut than they could at the study’s outset.
Hannah Ianelli is a new kid these days. The 11-year-old girl from the Boston area has good reason to grin, now that she’s finished a peanut oral immunotherapy trial that involved getting shots of the asthma drug omalizumab (or Xolair). Going out for dinner with her family, eating at a friend’s house, or heading to […]